ACADIA Pharmaceuticals Inc.
Pimavanserin for treating impulse control disorder
Last updated:
Abstract:
A method for treating a impulse control disorder in a patient comprising administering to the patient an effective amount of pimavanserin or a pharmaceutical acceptable salt thereof.
Status:
Grant
Type:
Utility
Filling date:
27 Apr 2018
Issue date:
5 Oct 2021